Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-03-11 @ 10:38 PM
Study NCT ID:
NCT03373760
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2017-12-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Sponsor:
Organization: